Latest news with #BioNTX
Associated Press
8 hours ago
- Business
- Associated Press
BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the Annual Southwest Tech Transfer Showcase, set for Wednesday, September 17th, at the 2025 iC³® Life Science & Healthcare Innovation Summit. For the first time, the Showcase has expanded beyond Texas, opening applications to academic institutions across Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee. This strategic expansion strengthens cross-state collaboration, elevates the visibility of early-stage life science technologies, and broadens opportunities for investors and innovation to reach commercialization. The Tech Transfer Showcase shines a spotlight on breakthrough technologies — many of which are still 'on the shelf' — and supports the development of the next generation of scientific leaders and entrepreneurs. Designed to assist academic institutions in presenting technologies available for licensing, collaboration, or acquisition, the program connects researchers with potential investors, industry executives, and strategic partners. 'This platform gives outstanding visibility into the deep bench of talent we have in our regional ecosystem,' said Kathleen Otto-Rosenblum, Chief Executive Officer at BioNTX. 'By highlighting early-stage technologies and connecting them to capital, collaborators, and commercial pathways, we are helping drive the future of innovation across the South-Central U.S.' A panel of experienced judges has reviewed each university's featured technology and selected the top six finalists to advance to the pitch event at the iC³ Summit: 'The Tech Transfer Showcase is where innovation meets opportunity,' said Chad Ronholdt, Chairman of the BioNTX Tech Transfer Committee and a seasoned life science entrepreneur. 'We are excited to expand this initiative beyond Texas and help surface cutting-edge research with real-world potential. It is a win for universities, entrepreneurs, and the broader health innovation community.' Each finalist will work closely with a Tech Transfer judge to refine their pitch, gaining valuable insights into commercial readiness, market fit, business models, and strategic partnerships. During the live Showcase at the iC³ Summit, finalists will present to an audience of biotech leaders, venture capitalists, and innovation stakeholders. The winner will be announced later that day and will receive a cash prize to support the advancement of their technology. About the 2025 iC³® Life Science & Healthcare Innovation Summit The 11th Annual BioNTX iC³® Life Science & Healthcare Innovation Summit brings together the community and bioscience and healthcare innovation leaders for a two-day event from Tuesday, September 16th — Wednesday, September 17th. The iC³ Summit — representing Innovation, Capital, Collaboration, and Commercialization — fosters cross-sector partnerships, showcases cutting-edge technologies, and explores the latest advancements in the life sciences. About BioNTX BioNTX is the bioscience and healthcare innovation trade organization serving North Texas. The organization fosters innovation and community through collaborative networking events, high-level educational programming, professional development, market visibility, a purchasing consortium, and by being the voice for the North Texas biosciences and healthcare innovation community. Media Contact: Eric Moore Chief Communications Officer, BioNTX 972-679-6056 [email protected]
Associated Press
11-08-2025
- Business
- Associated Press
BHIANT Quarterly Update: North Texas Bio Innovation Gains Momentum with Workforce Development and Industry Collaboration
DALLAS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BHIANT, the workforce development arm of BioNTX, is charting new ground in biotechnology talent development and industry collaboration, strengthening North Texas' position as a rising life sciences powerhouse. With a clear mission to innovate health and empower communities, BHIANT has made significant strides this quarter in addressing workforce gaps, advancing early-stage career pipelines, and deepening regional partnerships between academia, industry, and healthcare systems. Q1 2025: A Record-Setting Start BHIANT's Q1 2025 Sector Partnership Meeting reached a major milestone with record attendance, underscoring the region's growing commitment to life sciences collaboration. The gathering brought together executives from hospital systems, biotech companies, academic institutions, and economic development entities, all united in shaping the strategic growth of North Texas' biotechnology and healthcare talent pipeline. 'BHIANT is more than a workforce program—it is the connective tissue driving regional competitiveness, workforce readiness, and equitable access to biotech careers,' said Kathleen Otto-Rosenblum, CEO of BioNTX. 'North Texas is not just participating in the biotech revolution—it is leading it.' Real Impact, Real Jobs BHIANT's initiatives continue to generate tangible results: 'Through EDA funding, the Collin College Biotechnology Program has seen strong retention rates—most students continue to higher education or directly into the workforce,' said Dr. Bridgette Kirkpatrick, Director of Workforce Programs at Collin College. Early Workforce Pipeline: From High School to High-Impact Careers BHIANT, in partnership with DeSoto ISD, launched a first-of-its-kind high school pharmaceutical cGMP (Current Good Manufacturing Practice) program. This innovative program creates direct career pathways into biotechnology for non-college-bound students, broadening access and diversifying the region's biotech workforce. 'We are setting the standard for what an early workforce pipeline can look like,' said Dr. Usamah Rodgers, Superintendent of DeSoto ISD. 'This is equity in action—creating opportunities where few existed before.' Strengthening North Texas' Bioeconomy These efforts directly support North Texas' emergence as the number one Texas metro for Carnegie R1 and R2 Research Universities (Source: Dallas Regional Chamber, 2024 ) and solidify the region's reputation as a magnet for innovation, investment, and talent in the life sciences sector. As the North Texas biotech ecosystem grows, BHIANT will continue its mission of fostering collaboration, empowering innovation, and expanding access to transformative resources—ensuring that the region's growth is both competitive and inclusive. About BHIANT BHIANT (Biotechnology & Healthcare Industry Alliance of North Texas) is the workforce and talent development arm of BioNTX, designed to support the biotechnology, biomanufacturing, and healthcare industries by building a skilled, inclusive workforce, increasing career awareness, and attracting investment to North Texas. About BioNTX BioNTX is the bioscience and healthcare innovation industry trade organization for North Texas. We connect, advocate for, and empower stakeholders across academia, healthcare, startups, and enterprise to grow a resilient, collaborative, and globally competitive innovation ecosystem. Media Contact: Eric Moore Chief Communications Officer, BioNTX 972-679-6056 [email protected]
